BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | - | - | - | - | - |
What is the latest Contingent Liabilities ratio of BALAXI PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Contingent Liabilities of BALAXI PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Contingent Liabilities of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹108.9 Cr | -0.9% | -18.3% | -63.2% | Stock Analytics | |
| ADANI ENTERPRISES | ₹279,840.0 Cr | 2.5% | 9.8% | 5.7% | Stock Analytics | |
| REDINGTON | ₹21,948.3 Cr | -2.7% | -6.9% | -2.8% | Stock Analytics | |
| HONASA CONSUMER | ₹9,862.0 Cr | 1.9% | 14.5% | 33.6% | Stock Analytics | |
| MMTC | ₹9,292.5 Cr | -1% | -10.9% | 8.1% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹7,808.3 Cr | -3.3% | -8.5% | 16% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -0.9% |
-18.3% |
-63.2% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses